90 related articles for article (PubMed ID: 10770092)
21. Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies.
Jastaniah W; Harmatz P; Pakbaz Z; Fischer R; Vichinsky E; Walters MC
Pediatr Blood Cancer; 2008 Feb; 50(2):319-24. PubMed ID: 17557314
[TBL] [Abstract][Full Text] [Related]
22. Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature.
Cosman F; Baz-Hecht M; Cushman M; Vardy MD; Cruz JD; Nieves JW; Zion M; Lindsay R
Thromb Res; 2005; 116(1):1-13. PubMed ID: 15850603
[TBL] [Abstract][Full Text] [Related]
23. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS
J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959
[TBL] [Abstract][Full Text] [Related]
24. Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability.
Ataga KI; Cappellini MD; Rachmilewitz EA
Br J Haematol; 2007 Oct; 139(1):3-13. PubMed ID: 17854302
[TBL] [Abstract][Full Text] [Related]
25. Normal sublingual microcirculation during painful crisis in sickle cell disease.
van Beers EJ; Goedhart PT; Unger M; Biemond BJ; Ince C
Microvasc Res; 2008 May; 76(1):57-60. PubMed ID: 18423765
[TBL] [Abstract][Full Text] [Related]
26. Tissue factor pathway inhibitor, natural coagulation inhibitors and hemostatic activation markers in patients with acute coronary syndromes.
Al-Nozha MM; Abdel-Gader AG; Arafah MR; Al-Maatouq MA; Al-Shahid MS; Al-Harthi SS; Khan NB; Abdullah MA
Saudi Med J; 2005 Jun; 26(6):937-42. PubMed ID: 15983678
[TBL] [Abstract][Full Text] [Related]
27. Circadian variations in natural coagulation inhibitors protein C, protein S and antithrombin in healthy men: a possible association with interleukin-6.
Undar L; Ertuğrul C; Altunbaş H; Akça S
Thromb Haemost; 1999 Apr; 81(4):571-5. PubMed ID: 10235441
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary function studies in Kuwaiti children with sickle cell disease and elevated Hb F.
Hijazi Z; Onadeko BO; Khadadah M; Haider MZ; Adekile AD; Al-Habashi H
Int J Clin Pract; 2005 Feb; 59(2):163-7. PubMed ID: 15854191
[TBL] [Abstract][Full Text] [Related]
29. Thrombogenesis in sickle cell disease.
Tomer A; Harker LA; Kasey S; Eckman JR
J Lab Clin Med; 2001 Jun; 137(6):398-407. PubMed ID: 11385360
[TBL] [Abstract][Full Text] [Related]
30. A Comparison of Hemostatic Changes in Splenectomized and Nonsplenectomized β-Thalassemia Intermedia Patients.
Hashemieh M; Azarkeivan A; Sheibani K
J Pediatr Hematol Oncol; 2016 Nov; 38(8):636-641. PubMed ID: 27606436
[TBL] [Abstract][Full Text] [Related]
31. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
[TBL] [Abstract][Full Text] [Related]
32. Hemostatic alterations in sickle cell disease: relationships to disease pathophysiology.
Stuart MJ; Setty BN
Pediatr Pathol Mol Med; 2001; 20(1):27-46. PubMed ID: 12673843
[TBL] [Abstract][Full Text] [Related]
33. "Minor" hemoglobinopathies: a risk factor for asthma.
Palma-Carlos AG; Palma-Carlos ML; Costa AC
Eur Ann Allergy Clin Immunol; 2005 May; 37(5):177-82. PubMed ID: 15984316
[TBL] [Abstract][Full Text] [Related]
34. Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy.
Westerman M; Pizzey A; Hirschman J; Cerino M; Weil-Weiner Y; Ramotar P; Eze A; Lawrie A; Purdy G; Mackie I; Porter J
Br J Haematol; 2008 Jul; 142(1):126-35. PubMed ID: 18422994
[TBL] [Abstract][Full Text] [Related]
35. Effects of high-dose methotrexate on the hemostatic system in childhood acute lymphoblastic leukemia.
Totan M; Dagdemir A; Ak AR; Albayrak D; Kucukoduk S
Med Pediatr Oncol; 2001 Apr; 36(4):429-33. PubMed ID: 11260565
[TBL] [Abstract][Full Text] [Related]
36. Effects of replacement fluids on coagulation system used for therapeutic plasma exchange.
Tek I; Arslan O; Arat M; Ozcan M; Akdağ B; Ilhan O
Transfus Apher Sci; 2003 Feb; 28(1):3-7. PubMed ID: 12620262
[TBL] [Abstract][Full Text] [Related]
37. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients.
Malyszko J; Malyszko JS; Kozminski P; Pawlak K; Mysliwiec M
Nephrology (Carlton); 2007 Jun; 12(3):246-53. PubMed ID: 17498119
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation.
Jahangiri M; Kreutzer J; Zurakowski D; Bacha E; Jonas RA
J Thorac Cardiovasc Surg; 2000 Oct; 120(4):778-82. PubMed ID: 11003762
[TBL] [Abstract][Full Text] [Related]
39. Baseline levels of plasma endothelin-1 (ET-1) and changes during transfusion in thalassemic patients.
Viprakasit V; Kankirawatana S; Akarasereenont P; Durongpisitkul K; Chotewuttakorn S; Tanphaichitr VS
Am J Hematol; 2002 Jul; 70(3):260-2. PubMed ID: 12118430
[TBL] [Abstract][Full Text] [Related]
40. Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects.
De CR; Rocca B; Marchioli R; Landolfi R
Thromb Haemost; 2002 Jan; 87(1):58-67. PubMed ID: 11848457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
